Roth/MKM maintained a positive stance on Canopy Growth (NASDAQ:CGC) shares, despite reducing the price target to C$10 from the previous C$15. The firm continues to endorse a Buy rating for the ...

Canopy’s stock reversed on earnings after seeing a rally sparked by the possibility of marijuana reform in the U.S.

BofA lowered the firm’s price target on Canopy Growth (CGC) to C$2 from C$5 and keeps an Underperform rating on the shares following what the ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Ansell (ANSLF – Research Report) and Canopy Growth (CGC – ...

Canopy Growth (NASDAQ:CGC) shares lost ~15% in the premarket on Friday after the Canadian cannabis operator reported a wider-than-anticipated loss for Q3 fiscal 2025 driven by declining revenue ...

Not only does Canopy Growth still have a lot of debt remaining, its cash flow from operations continues to be negative. Often, tangible book value can help support a stock price, but this doesn't ...

Canopy Growth (TSE:WEED – Get Free Report) had its target price lowered by equities research analysts at ATB Capital from C$4.00 to C$3.20 in a research note issued on Monday,BayStreet.CA reports. The ...

Canopy Growth Corp.’s stock fell sharply as the Canadian cannabis company’s wider-than-expected third-quarter loss chilled a recent rally in its share price. At the closing bell, Canopy Growth ...

Canopy Growth Corp.'s stock fell sharply as the Canadian cannabis company's wider-than-expected third-quarter loss chilled a recent rally in its share price. Canopy Growth's stock fell 18% to $2. ...